Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers

Clinical trial NCT05099510 · COMPLETED

Trial details

NCT number: NCT05099510
Sponsor: XBiotech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2022-01-19
Primary completion: 2022-08-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.